Confirmation of late-stage discussions with SpringWorks on potential acquisition
We react to press reports and confirm late-stage discussions with SpringWorks Therapeutics, Inc. on a potential acquisition.
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014
Merck KGaA, Darmstadt, Germany, reacts to press reports and confirms late-stage discussions with SpringWorks Therapeutics, Inc. on a potential acquisition. The parties are in discussion on the basis of a price of around $47 per share.
Merck KGaA, Darmstadt, Germany, notes that no final decision has been taken and no legally binding agreement has been entered into.
End of inside information
Downloads
-
ad-hoc-04-24-2025-na.pdf
About Merck KGaA, Darmstadt, Germany
Merck KGaA, Darmstadt, Germany, a leading science and technology company, operates across life science, healthcare and electronics. More than 62,000 employees work to make a positive difference to millions of people’s lives every day by creating more joyful and sustainable ways to live. From providing products and services that accelerate drug development and manufacturing as well as discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices – the company is everywhere. In 2024, Merck KGaA, Darmstadt, Germany, generated sales of € 21.2 billion in 65 countries.
The company holds the global rights to the name and trademark “Merck” internationally. The only exceptions are the United States and Canada, where the business sectors of Merck KGaA, Darmstadt, Germany, operate as MilliporeSigma in life science, EMD Serono in healthcare and EMD Electronics in electronics. Since its founding in 1668, scientific exploration and responsible entrepreneurship have been key to the company’s technological and scientific advances. To this day, the founding family remains the majority owner of the publicly listed company.
All Merck KGaA, Darmstadt, Germany, press releases are distributed by e-mail at the same time they become available on the EMD Group website. In case you are a resident of the USA or Canada, please go to www.emdgroup.com/subscribe to register for your online, change your selection or discontinue this service.
Related News
-
Press Releases
Merck KGaA, Darmstadt, Germany, to Acquire US Biopharma Company SpringWorks ...
Merck KGaA, Darmstadt, Germany, and SpringWorks Therapeutics, have entered into a definitive agreement for us to acquire SpringWorks.
2025/04/28